• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌前哨淋巴结活检中吲哚菁绿与亚甲蓝联合应用的临床研究。

Clinical study of combined application of indocyanine green and methylene blue for sentinel lymph node biopsy in breast cancer.

机构信息

Department of Breast Surgery, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.

出版信息

Medicine (Baltimore). 2021 Apr 16;100(15):e25365. doi: 10.1097/MD.0000000000025365.

DOI:10.1097/MD.0000000000025365
PMID:33847634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8051969/
Abstract

OBJECTIVE

This study aims to investigate the feasibility of combined application of indocyanine green (ICG) and methylene blue (MB) for sentinel lymph node biopsy (SLNB) in patients with early breast cancer.

METHODS

A total of 415 patients who underwent SLNB and axillary lymph node dissection were enrolled. Sentinel lymph node (SLN) was assessed in 197 patients with ICG and MB combination method, while, the other 218 patients were detected by MB method alone. During surgery, all SLNs were harvested for pathological examination. Then the detection rate and false negative rate of SLNs were comparatively analyzed between the 2 groups.

RESULTS

In the combined ICG and MB group, the detection rate of SLNs was 96.9%, significantly higher than that of MB group, which was 89.7% (P < .05). Similarly, in combined group, the average number of SLNs per patient was 3.0, much higher than that of MB group, which was 2.1 (P < .05). There was no statistically significant difference in false negative rate between combined group and MB alone group, which was 7.3% and 10.5%, respectively (P = .791).

CONCLUSION

The combined application of ICG and MB for SLNB is much more effective than MB alone in detecting SLNs.

摘要

目的

本研究旨在探讨吲哚菁绿(ICG)和亚甲蓝(MB)联合应用于早期乳腺癌前哨淋巴结活检(SLNB)的可行性。

方法

共纳入 415 例接受 SLNB 和腋窝淋巴结清扫术的患者。197 例患者采用 ICG 和 MB 联合方法评估前哨淋巴结(SLN),另 218 例患者仅采用 MB 方法检测。术中均采集所有 SLN 进行病理检查。然后比较两组 SLN 的检出率和假阴性率。

结果

在 ICG 和 MB 联合组中,SLN 的检出率为 96.9%,明显高于 MB 组的 89.7%(P<0.05)。同样,在联合组中,每位患者的平均 SLN 数为 3.0,明显高于 MB 组的 2.1(P<0.05)。联合组和 MB 组的假阴性率分别为 7.3%和 10.5%,差异无统计学意义(P=0.791)。

结论

ICG 和 MB 联合应用于 SLNB 检测 SLN 比 MB 单独应用更有效。

相似文献

1
Clinical study of combined application of indocyanine green and methylene blue for sentinel lymph node biopsy in breast cancer.乳腺癌前哨淋巴结活检中吲哚菁绿与亚甲蓝联合应用的临床研究。
Medicine (Baltimore). 2021 Apr 16;100(15):e25365. doi: 10.1097/MD.0000000000025365.
2
Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.对比吲哚菁绿、蓝染料及二者联合引导下的前哨淋巴结活检在乳腺癌患者中的应用:一项前瞻性队列研究。
World J Surg Oncol. 2017 Nov 2;15(1):196. doi: 10.1186/s12957-017-1264-7.
3
Indocyanine green combined with methylene blue versus methylene blue alone for sentinel lymph node biopsy in breast cancer: a retrospective study.吲哚菁绿联合亚甲蓝与单纯亚甲蓝在乳腺癌前哨淋巴结活检中的应用:一项回顾性研究。
BMC Surg. 2023 May 17;23(1):133. doi: 10.1186/s12893-023-02037-z.
4
Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.低成本印度花菁绿荧光示踪法在早期乳腺癌前哨淋巴结活检中替代双染料(放射性胶体和蓝染料)技术的前瞻性双臂比较研究。
Clin Breast Cancer. 2020 Oct;20(5):e576-e583. doi: 10.1016/j.clbc.2020.03.013. Epub 2020 Apr 6.
5
Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.锝-99m 吲哚菁绿与锝-99m 甲叉蓝用于早期子宫内膜癌前哨淋巴结活检。
Int J Gynecol Cancer. 2020 Mar;30(3):311-317. doi: 10.1136/ijgc-2019-000923. Epub 2020 Jan 27.
6
Indocyanine green detects sentinel lymph nodes in early breast cancer.吲哚菁绿可检测早期乳腺癌前哨淋巴结。
J Int Med Res. 2017 Apr;45(2):514-524. doi: 10.1177/0300060516687149. Epub 2017 Jan 1.
7
Indocyanine Green and Methylene Blue Dye Guided Sentinel Lymph Node Biopsy in Early Breast Cancer: A Single-Center Retrospective Survival Study in 1574 Patients.吲哚菁绿和亚甲蓝染料引导的早期乳腺癌前哨淋巴结活检:1574 例患者的单中心回顾性生存研究。
Clin Breast Cancer. 2023 Jun;23(4):408-414. doi: 10.1016/j.clbc.2023.02.002. Epub 2023 Feb 11.
8
Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer.早期乳腺癌吲哚菁绿前哨淋巴结活检的短期和长期结果。
World J Surg Oncol. 2022 Aug 9;20(1):253. doi: 10.1186/s12957-022-02719-7.
9
Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer.乳腺癌前哨淋巴结活检中,对比增强超声联合蓝染料与吲哚菁绿荧光联合蓝染料的初步研究。
BMC Cancer. 2019 Oct 11;19(1):939. doi: 10.1186/s12885-019-6165-4.
10
Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.在乳腺癌前哨淋巴结活检中额外使用蓝色染料辅助吲哚菁绿的临床效用。
J Surg Res. 2017 Jul;215:88-92. doi: 10.1016/j.jss.2017.03.038. Epub 2017 Apr 1.

引用本文的文献

1
Indocyanine Green Marking of Axillary Sentinel Lymph Nodes in Early Breast Cancer.早期乳腺癌腋窝前哨淋巴结的吲哚菁绿标记
Geburtshilfe Frauenheilkd. 2024 Nov 12;85(6):631-638. doi: 10.1055/a-2436-1699. eCollection 2025 Jun.
2
Innovations in the localization techniques for non-palpable breast lesions: Make invisible visible.不可触及乳腺病变定位技术的创新:让不可见变为可见。
Breast. 2025 Jun;81:104430. doi: 10.1016/j.breast.2025.104430. Epub 2025 Feb 26.
3
Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: A multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact.
吲哚菁绿与常规示踪剂在乳腺癌前哨淋巴结活检中的比较:临床有效性、安全性、组织和经济影响的多学科评估。
PLoS One. 2024 Aug 29;19(8):e0309336. doi: 10.1371/journal.pone.0309336. eCollection 2024.
4
Determining Accurate Dye Combinations for Sentinel Lymph Node Detection: A Systematic Review.确定用于前哨淋巴结检测的准确染料组合:一项系统综述。
Plast Reconstr Surg Glob Open. 2024 Feb 8;12(2):e5598. doi: 10.1097/GOX.0000000000005598. eCollection 2024 Feb.
5
An Updated Review on the Emerging Role of Indocyanine Green (ICG) as a Sentinel Lymph Node Tracer in Breast Cancer.关于吲哚菁绿(ICG)作为乳腺癌前哨淋巴结示踪剂新作用的最新综述
Cancers (Basel). 2023 Dec 8;15(24):5755. doi: 10.3390/cancers15245755.
6
Application of fluorescence endoscopy with methylene blue dye and indocyanine green dual-tracer method in sentinel lymph node biopsy for women with breast cancer.荧光内镜联合亚甲蓝染料及吲哚菁绿双示踪剂法在乳腺癌患者前哨淋巴结活检中的应用
Gland Surg. 2023 Jun 30;12(6):780-790. doi: 10.21037/gs-22-469. Epub 2023 Jun 12.
7
New techniques versus standard mapping for sentinel lymph node biopsy in breast cancer: a systematic review and meta-analysis.新技术与标准绘图法在乳腺癌前哨淋巴结活检中的比较:系统评价和荟萃分析。
Updates Surg. 2023 Sep;75(6):1699-1710. doi: 10.1007/s13304-023-01560-1. Epub 2023 Jun 16.
8
The primary application of indocyanine green fluorescence imaging in surgical oncology.吲哚菁绿荧光成像在外科肿瘤学中的主要应用。
Front Surg. 2023 Feb 17;10:1077492. doi: 10.3389/fsurg.2023.1077492. eCollection 2023.
9
Recent Progress in Second Near-Infrared (NIR-II) Fluorescence Imaging in Cancer.癌症中近二次近红外(NIR-II)荧光成像的最新进展。
Biomolecules. 2022 Jul 28;12(8):1044. doi: 10.3390/biom12081044.
10
Intraoperative fluorescence molecular imaging accelerates the coming of precision surgery in China.术中荧光分子成像加速中国精准手术的到来。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2531-2543. doi: 10.1007/s00259-022-05730-y. Epub 2022 Mar 1.